Hazel Lote
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
-
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
-
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Ian Chau (8 shared papers)Marta Capelán (2 shared papers)Stefania Redana (2 shared papers)Adam Sharp (2 shared papers)Vejay N. Vakharia (1 shared paper)Marco Gerlinger (1 shared paper)Rille Pihlak (1 shared paper)Naureen Starling (4 shared papers)
- Journals
- Cancer Treatment Reviews (2 papers)Annals of Oncology (2 papers)The Breast (1 paper)Clinical Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United KingdomSwedenItaly
In The Last Decade
Hazel Lote
16 papers receiving 195 citations
Peers
Comparison fields: 5 of 44
- Oncology 116
- Pulmonary and Respiratory Medicine 78
- Cancer Research 22
- Gastroenterology 8
- Radiology, Nuclear Medicine and Imaging 30
Countries citing papers authored by Hazel Lote
This map shows the geographic impact of Hazel Lote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Lote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Lote more than expected).
Fields of papers citing papers by Hazel Lote
This network shows the impact of papers produced by Hazel Lote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Lote. The network helps show where Hazel Lote may publish in the future.
Co-authors
The 25 scholars most cited alongside Hazel Lote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 60 | |
| 2 | 2014 | 28 | |
| 3 | 2016 | 24 | |
| 4 | 2022 | 18 | |
| 5 | 2016 | 11 | |
| 6 | 2018 | 9 | |
| 7 | 2012 | 9 | |
| 8 | 2014 | 8 | |
| 9 | 2022 | 7 | |
| 10 | 2013 | 7 | |
| 11 | 2013 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2023 | 0 |
About Hazel Lote
Hazel Lote is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 198 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal and Anal Carcinomas (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), MicroRNA in disease regulation (2 papers), Breast Cancer Treatment Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Oncology (116 citations), Pulmonary and Respiratory Medicine (78 citations), Cancer Research (22 citations), Gastroenterology (8 citations) and Radiology, Nuclear Medicine and Imaging (30 citations). Hazel Lote has collaborated with scholars based in United Kingdom, Sweden and Italy. Frequent co-authors include Ian Chau, Marta Capelán, Stefania Redana, Adam Sharp, Vejay N. Vakharia, Marco Gerlinger, Rille Pihlak, Naureen Starling, Nicola Valeri and Yee Liang Thian. Their work appears in journals such as Cancer Treatment Reviews, Annals of Oncology, The Breast, Clinical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.